PD-1 anticorps (AA 25-167)
-
- Antigène Voir toutes PD-1 (PDCD1) Anticorps
- PD-1 (PDCD1) (Programmed Cell Death 1 (PDCD1))
- Fragment
- single-domain Antibody (sdAb)
-
Épitope
- AA 25-167
-
Reactivité
- Humain
-
Hôte
-
Llama
-
Clonalité
- Monoclonal
-
Conjugué
- Cet anticorp PD-1 est non-conjugé
-
Application
- Flow Cytometry (FACS), ELISA
- Purification
- PD-1 Antibody is affinity chromatography purified via Nickel column.
- Immunogène
- PD-1 antibody was raised against a recombinant protein corresponding to amino acids 25 - 167 of human PD-1.
- Clone
- F1-2A8
- Top Product
- Discover our top product PDCD1 Anticorps primaire
-
-
- Indications d'application
- PD-1 antibody can be used for detection of PD-1 by ELISA and FACS (10 μ,g/mL).
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- 1 mg/mL
- Buffer
- PD-1 Antibody is supplied in PBS containing 0.02 % sodium azide.
- Agent conservateur
- Sodium azide
- Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Stock
- -20 °C
- Stockage commentaire
- PD-1 antibody should be stored in working aliquots at -20°C, stable for up to one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.
-
- Antigène
- PD-1 (PDCD1) (Programmed Cell Death 1 (PDCD1))
- Autre désignation
- PD-1 (PDCD1 Produits)
- Synonymes
- anticorps CD279, anticorps PD-1, anticorps PD1, anticorps SLEB2, anticorps hPD-1, anticorps hPD-l, anticorps Ly101, anticorps Pdc1, anticorps programmed cell death 1, anticorps PDCD1, anticorps Pdcd1
- Sujet
- PD-1 Antibody: Cell-mediated immune responses are initiated by T lymphocytes that are themselves stimulated by cognate peptides bound to MHC molecules on antig en-presenting cells (APC). T-cell activation is generally self-limited as activated T cells express receptors such as PD-1 (also known as PDCD-1) that mediate inhibitory signals from the APC. PD-1 can bind two different but related ligands, PDL-1 and PDL-2. Upon binding to either of these ligands, signals generated by PD-1 inhibit the activation of the immune response in the absence of "danger signals" such as LPS or other molecules associated with bacteria or other pathogens. Evidence for this is seen in PD1-null mice who exhibit hyperactivated immune systems and autoimmune diseases.
- ID gène
- 5133
- NCBI Accession
- NP_005009
- UniProt
- Q15116
- Pathways
- Cancer Immune Checkpoints
-